Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Price:
523.69
USD
-3%
Market Closed
Market Cap:
$12B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
Sunstone Hotel Investors Inc
NYSE:SHO
|
US |
|
Applied Materials Inc
NASDAQ:AMAT
|
US |
|
Adani Power Ltd
NSE:ADANIPOWER
|
IN |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
K
|
Keystone Realtors Ltd
NSE:RUSTOMJEE
|
IN |
|
Austal Ltd
ASX:ASB
|
AU |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
L
|
Land and Houses PCL
SET:LH
|
TH |
|
H
|
Humana Inc
SWB:HUM
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
Fleetpartners Group Ltd
ASX:FPR
|
AU |
Wall St Price Targets
MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc
Wall Street analysts forecast MDGL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.
Lowest Forecast
Price Target
555.5
USD
6% Upside
Average Forecast
Price Target
691.65
USD
32% Upside
Highest Forecast
Price Target
1 012.2
USD
93% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDGL's stock price target?
Price Target
691.65
USD
691.65
USD
According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 26%.
